Current challenges in lung cancer early detection biomarkers

European Journal of Cancer

Volumn 45, Issue SUPPL. 1, 2009, Pages 377-378

  Montuenga, Luis M ^a   Pio, Ruben ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PLASMA PROTEIN; RNA BINDING PROTEIN; TUMOR MARKER;

AIRWAY OBSTRUCTION; ARTICLE; BODY FLUID; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; EMPHYSEMA; ENVIRONMENTAL EXPLOITATION; EPIGENETICS; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK POPULATION; LOW ENERGY RADIATION; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; MOLECULAR THERAPY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RISK ASSESSMENT; RNA PROCESSING; RNA SPLICING; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; SPUTUM; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; TRACHEOBRONCHIAL TOILET;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MUTATION; RNA, MESSENGER; RNA, NEOPLASM; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 70349291196     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(09)70055-3     Document Type: Article

References (16)

1. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
2. Amos C.I., Wu X., Broderick P., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40 (2008) 616-622
3. De Torres J.P., Bastarrika G., Wisnivesky J.P., et al. Assessing the relationship between lung cancer risk and emphysema detected onlow-dose CT of the chest. Chest 132 (2007) 1932-1938
4. Sozzi G., Roz L., Conte D., et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. Am J Respir Crit Care Med 179 (2009) 69-74
5. Sozzi G., Conte D., Leon M., et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21 (2003) 3902-3908
6. Pajares M.J., Zudaire I., Lozano M.D., et al. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features. Cancer Epidemiol Biomarkers Prev 15 (2006) 373-380
7. Ding L., Getz G., Wheeler D.A., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455 (2008) 1069-1075
8. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K., Taylor J.M., et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14 (2008) 822-827
9. Weir B.A., Woo M.S., Getz G., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450 (2007) 893-898
10. Pajares M.J., Ezponda T., Catena R., et al. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8 (2007) 349-357
11. Castaño Z., Vergara-Irigaray N., Pajares M.J., et al. Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells. Int J Cancer 122 (2008) 1512-1520
12. Belinsky S.A. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 4 (2004) 707-717
13. Patz Jr. E.F., Campa M.J., Gottlin E.B., et al. Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25 (2007) 5578-5583
14. Spira A., Beane J.E., Shah V., et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13 (2007) 361-366
15. Qiu J., Choi G., Li L., et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 26 (2008) 5060-5066
16. Pepe M.S., Etzioni R., Feng, et al. Phases of biomarker development for early detection of cancer. JNCI 93 (2001) 1054-1061